Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Fernandez-Reyes

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1996
Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysisP Iglesias, C Grande, J Méndez, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1996
Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactateR Selgas, M A Bajo, M J Fernandez-Reyes, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1994
CAPD for treatment of ESRD patients with ascites secondary to liver cirrhosisM A Bajo, R Selgas, C Jimenez, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1994
Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term studyR Selgas, M J Fernandez-Reyes, E Bosque, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: the influence of urea and creatinine kineticsR Selgas, M A Bajo, M J Fernandez-Reyes, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 1, 1995
Increased response to subcutaneous erythropoietin on type I diabetic patients on CAPD: is there a synergistic effect with insulin?M J Fernandez-Reyes, R Selgas, M A Bajo, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Peritoneal dialysis in liver disordersR Selgas, M A Bajo, C Jimenez, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1995
Mitral annular calcification in CAPD patients with a low degree of hyperparathyroidism. An analysis of other possible risk factorsM J Fernandez-Reyes, M Auxiliadora Bajo, P Robles, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1993
Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failureF de Alvaro, M J Castro, F Dapena, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Staphylococcus aureus nasal carrier status (SANCS) in CAPD patients; is it induced or favored by subcutaneous rHu-erythropoietin?R Selgas, M J Castro, M A Bajo, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1996
Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysisP Iglesias, C Grande, J Méndez, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1996
Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactateR Selgas, M A Bajo, M J Fernandez-Reyes, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1994
CAPD for treatment of ESRD patients with ascites secondary to liver cirrhosisM A Bajo, R Selgas, C Jimenez, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1994
Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term studyR Selgas, M J Fernandez-Reyes, E Bosque, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: the influence of urea and creatinine kineticsR Selgas, M A Bajo, M J Fernandez-Reyes, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 1, 1995
Increased response to subcutaneous erythropoietin on type I diabetic patients on CAPD: is there a synergistic effect with insulin?M J Fernandez-Reyes, R Selgas, M A Bajo, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Peritoneal dialysis in liver disordersR Selgas, M A Bajo, C Jimenez, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1995
Mitral annular calcification in CAPD patients with a low degree of hyperparathyroidism. An analysis of other possible risk factorsM J Fernandez-Reyes, M Auxiliadora Bajo, P Robles, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1993
Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failureF de Alvaro, M J Castro, F Dapena, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Staphylococcus aureus nasal carrier status (SANCS) in CAPD patients; is it induced or favored by subcutaneous rHu-erythropoietin?R Selgas, M J Castro, M A Bajo, et al.
Pageof 2